Total Payments
$35,968
2024 Payments
$915.32
Companies
12
Transactions
49
Medicare Patients
688
Medicare Billing
$145,317
Payment Breakdown by Category
Consulting$22,783 (63.3%)
Other$7,450 (20.7%)
Travel$3,474 (9.7%)
Food & Beverage$2,260 (6.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $22,783 | 11 | 63.3% |
| Honoraria | $3,950 | 2 | 11.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,500 | 1 | 9.7% |
| Travel and Lodging | $3,474 | 15 | 9.7% |
| Food and Beverage | $2,260 | 20 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $7,640 | 8 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $7,533 | 4 | $0 (2024) |
| Biom'Up SA | $6,771 | 10 | $0 (2019) |
| Sirtex Medical Inc | $4,661 | 6 | $0 (2022) |
| Biom'Up France SAS | $3,713 | 5 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $3,500 | 1 | $0 (2018) |
| Intuitive Surgical, Inc. | $1,456 | 10 | $0 (2018) |
| Gyrus ACMI, Inc. | $350.00 | 1 | $0 (2018) |
| Medical Device Business Services, Inc. | $142.85 | 1 | $0 (2022) |
| HISTOSONICS,INC. | $109.82 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $915.32 | 2 | AstraZeneca Pharmaceuticals LP ($805.50) |
| 2022 | $10,079 | 11 | Boston Scientific Corporation ($7,640) |
| 2021 | $2,070 | 3 | AstraZeneca Pharmaceuticals LP ($1,880) |
| 2020 | $8,886 | 7 | Biom'Up France SAS ($3,523) |
| 2019 | $2,081 | 4 | Sirtex Medical Inc ($1,849) |
| 2018 | $10,549 | 13 | Biom'Up SA ($6,603) |
| 2017 | $1,387 | 9 | Intuitive Surgical, Inc. ($1,360) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/12/2024 | HISTOSONICS,INC. | — | Food and Beverage | Cash or cash equivalent | $109.82 | General |
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $805.50 | General |
| 11/28/2022 | Boston Scientific Corporation | General - IO Ablation (Device) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: General - IO Ablation_PI | ||||||
| 09/24/2022 | Medical Device Business Services, Inc. | CONDUIT (Device) | Food and Beverage | In-kind items and services | $142.85 | General |
| Category: Spine | ||||||
| 08/12/2022 | Boston Scientific Corporation | General - Therapies (Device) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: General - Therapies_PI | ||||||
| 07/08/2022 | Boston Scientific Corporation | General - Therapies (Device) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: General - Therapies_PI | ||||||
| 05/20/2022 | Boston Scientific Corporation | General - Therapies (Device) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: General - Therapies_PI | ||||||
| 05/20/2022 | Boston Scientific Corporation | General - Therapies (Device) | Travel and Lodging | Cash or cash equivalent | $716.20 | General |
| Category: General - Therapies_PI | ||||||
| 05/20/2022 | Boston Scientific Corporation | General - Therapies (Device) | Travel and Lodging | Cash or cash equivalent | $173.33 | General |
| Category: General - Therapies_PI | ||||||
| 05/20/2022 | Boston Scientific Corporation | General - Therapies (Device) | Food and Beverage | Cash or cash equivalent | $127.38 | General |
| Category: General - Therapies_PI | ||||||
| 05/20/2022 | Boston Scientific Corporation | General - Therapies (Device) | Travel and Lodging | Cash or cash equivalent | $23.27 | General |
| Category: General - Therapies_PI | ||||||
| 04/19/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| Category: Oncology | ||||||
| 04/12/2022 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $148.35 | General |
| Category: Interventional Oncology | ||||||
| 12/22/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $1,879.50 | General |
| Category: Oncology | ||||||
| 09/16/2021 | Biom'Up France SAS | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $92.28 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 05/20/2021 | Biom'Up France SAS | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $97.93 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 09/04/2020 | Biom'Up France SAS | HemoBlast Bellows (Device) | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| Category: Hemostatic Agent | ||||||
| 06/16/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: Oncology | ||||||
| 03/05/2020 | Biom'Up France SAS | HemoBlast Bellows (Device) | Food and Beverage | In-kind items and services | $164.42 | General |
| Category: Hemostatic Agent | ||||||
| 03/05/2020 | Biom'Up France SAS | HemoBlast Bellows (Device) | Food and Beverage | In-kind items and services | $58.61 | General |
| Category: Hemostatic Agent | ||||||
| 02/05/2020 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Honoraria | Cash or cash equivalent | $2,200.00 | General |
| Category: Interventional Oncology | ||||||
| 01/30/2020 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $364.23 | General |
| Category: Interventional Oncology | ||||||
| 01/11/2020 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $98.96 | General |
| Category: Interventional Oncology | ||||||
| 05/29/2019 | Biom'Up SA | Hemoblast (Device) | Food and Beverage | In-kind items and services | $168.53 | General |
| Category: Surgical | ||||||
| 04/29/2019 | Cook Medical LLC | Cook Medical Metal Stents (Device) | Food and Beverage | Cash or cash equivalent | $63.87 | General |
| Category: Endoscopy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 156 | 186 | $141,981 | $29,614 |
| 2021 | 10 | 270 | 322 | $240,184 | $51,485 |
| 2020 | 9 | 262 | 301 | $328,541 | $64,218 |
Total Patients
688
Total Services
809
Medicare Billing
$145,317
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 87 | 117 | $87,151 | $18,341 | 21.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 37 | 37 | $33,700 | $7,095 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $15,252 | $2,926 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $5,878 | $1,251 | 21.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 95 | 121 | $77,430 | $18,524 | 23.9% |
| 47562 | Removal of gallbladder using an endoscope | Facility | 2021 | 20 | 20 | $59,437 | $10,806 | 18.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 37 | 37 | $32,286 | $7,367 | 22.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $18,073 | $3,491 | 19.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 44 | $12,980 | $2,591 | 20.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 14 | $11,550 | $2,352 | 20.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 15 | 17 | $7,966 | $1,986 | 24.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 18 | $7,614 | $1,609 | 21.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 12 | $5,685 | $1,399 | 24.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 13 | $7,163 | $1,359 | 19.0% |
| 47379 | Liver procedure using an endoscope | Facility | 2020 | 16 | 16 | $140,812 | $24,126 | 17.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 60 | 75 | $45,003 | $9,669 | 21.5% |
| 47562 | Removal of gallbladder using an endoscope | Facility | 2020 | 13 | 13 | $38,346 | $7,858 | 20.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 50 | 50 | $33,799 | $7,323 | 21.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 57 | 63 | $28,188 | $6,147 | 21.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 16 | $13,013 | $2,825 | 21.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 27 | $12,087 | $2,528 | 20.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 20 | $11,122 | $2,412 | 21.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 21 | $6,171 | $1,330 | 21.5% |
About Dr. Cristina Ferrone, M.D
Dr. Cristina Ferrone, M.D is a Surgical Oncology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316053192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cristina Ferrone, M.D has received a total of $35,968 in payments from pharmaceutical and medical device companies, with $915.32 received in 2024. These payments were reported across 49 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($22,783).
As a Medicare-enrolled provider, Ferrone has provided services to 688 Medicare beneficiaries, totaling 809 services with total Medicare billing of $145,317. Data is available for 3 years (2020–2022), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical Oncology
- Other Specialties Surgical Oncology
- Location Los Angeles, CA
- Active Since 08/22/2006
- Last Updated 08/09/2023
- Taxonomy Code 2086X0206X
- Entity Type Individual
- NPI Number 1316053192
Products in Payments
- General - Therapies (Device) $7,040
- HEMOBLAST Bellows (Device) $6,603
- SIR-Spheres Microspheres (Device) $4,661
- IMFINZI (Biological) $4,028
- HemoBlast Bellows (Device) $3,523
- IMFINZI (Drug) $2,700
- Da Vinci Surgical System (Device) $1,456
- General - IO Ablation (Device) $600.00
- HEMOBLAST BELLOWS (Device) $190.21
- Hemoblast (Device) $168.53
- CONDUIT (Device) $142.85
- Cook Medical Metal Stents (Device) $63.87
- ECHELON FLEX Stapler (Device) $26.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgical Oncology Doctors in Los Angeles
Karim Chamie, M.d, M.D
Surgical Oncology — Payments: $222,147
Surgical Oncology $222,147
Robert Reiter, Md, MD
Surgical Oncology — Payments: $170,624
Surgical Oncology $170,624
Lawrence Menendez, M.d, M.D
Surgical Oncology — Payments: $50,396
Surgical Oncology $50,396
Dr. Arnold Chin, Md, Phd, MD, PHD
Surgical Oncology — Payments: $35,897
Surgical Oncology $35,897
Dr. John Kang, M.d, M.D
Surgical Oncology — Payments: $33,340
Surgical Oncology $33,340
James Economou, Md, MD
Surgical Oncology — Payments: $26,550
Surgical Oncology $26,550